MARATTO

article · HIV Medicine

Assessment of weight gain in adult patients living with <scp>HIV</scp> receiving first‐line dolutegravir‐based or efavirenz‐based <scp>ART</scp> regimens in routine care clinics in Tshwane district, South Africa: An observational study

20243 citationsOpen accessUniversity of the Witwatersrand

Abstract

We report more weight gain among TLD than among TEE initiators, although to a lesser extent than previously reported. TEE-to-TLD switchers experienced less weight gain after TLD switch; return to health before receiving TLD may be a contributory factor. The current findings are reassuring for those switching to a DTG-based regimen.

Research topics

  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1111/hiv.13638

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.